| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-11 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |